Results 131 to 140 of about 4,820 (157)

Procedural Outcome and Long-Term Follow-Up of Patients Undergoing Epicardial or Endocardial Left Atrial Appendage Occlusion. [PDF]

J Clin Med
Nentwich K, Kaziashvilli N, Sauer E, Berkovitz A, Mueller J, Schade A, Barth S, Luesebrink U, Deneke T.   +8 more
europepmc   +1 more source

Percutaneous closure of residual leak after surgical left atrial appendage ligation: a case of stroke prevention in high-risk atrial fibrillation. [PDF]

BMC Cardiovasc Disord
Doğan M, Ateş AH, Çöteli C, Karakulak UN, Yorgun H, Sahiner ML, Kaya EB, Aytemir K.   +7 more
europepmc   +1 more source

Percutaneous left atrial appendage occlusion following failed surgical ligation for incessant left atrial appendage tachycardia: key role of multimodality imaging. [PDF]

Int J Cardiovasc Imaging
Okafor J, Mohammed A, Kailey B, Ali A, Kanagaratnam P, Casula R, Rana B.   +6 more
europepmc   +1 more source

Embolization of left atrial appendage occluders: review of the current evidence. [PDF]

REC Interv Cardiol
Martín-Arena MÁ, Galeote-García G, Lara-García A, Jurado-Román A, Jiménez-Valero S, Gonzálvez-García A, Tébar-Márquez D, Rivero-Santana B, Zubiaur J, Basile M, Valbuena-López S, Fernández-Gassó L, González-Gallarza RD, Moreno R.   +13 more
europepmc   +1 more source

Combined Single-Access Left Atrial Appendage Occlusion and Transcatheter Edge-to-Edge Repair for Mitral and Tricuspid Regurgitation. [PDF]

JACC Case Rep
Florescu AG, Neylon A, Duhamel S, Djebbar M, Akodad M, Garot P.   +5 more
europepmc   +1 more source

3-Year Outcomes From the Amplatzer Amulet Left Atrial Appendage Occluder Randomized Controlled Trial (Amulet IDE) [PDF]

JACC: Cardiovascular Interventions, 2023
BACKGROUND The Amulet (Abbott) left atrial appendage occluder investigational device exemption trial is the largest randomized trial evaluating the safety and effectiveness of the Amulet left atrial appendage occluder compared with the Watchman 2.5 ...
Mohamad Alkhouli, James Hermiller
exaly   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

What Have We Learned From the 3-Year Outcomes of the Amulet IDE Trial?

JACC: Cardiovascular Interventions, 2023

exaly